Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Addus HomeCare Corporation (NASDAQ:ADUS) has received an average rating of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $130.8750.

A number of research firms have recently issued reports on ADUS. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Citizens Jmp restated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Barclays raised their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a report on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Royal Bank Of Canada boosted their price objective on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th.

Addus HomeCare Stock Down 2.1%

ADUS opened at $115.55 on Monday. The firm has a market cap of $2.16 billion, a price-to-earnings ratio of 20.27, a PEG ratio of 1.58 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The firm’s 50-day simple moving average is $111.95 and its 200-day simple moving average is $102.96. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period last year, the firm posted $1.49 EPS. Equities research analysts anticipate that Addus HomeCare will post 6.3 EPS for the current fiscal year.

Insider Activity

In related news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently modified their holdings of the stock. Leeward Investments LLC MA increased its holdings in shares of Addus HomeCare by 9.4% in the first quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock valued at $11,318,000 after purchasing an additional 10,414 shares in the last quarter. Bank of America Corp DE raised its position in Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after purchasing an additional 32,714 shares during the last quarter. Summit Creek Advisors LLC acquired a new position in Addus HomeCare during the 2nd quarter worth $8,552,000. Vanguard Group Inc. lifted its holdings in Addus HomeCare by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after buying an additional 10,501 shares in the last quarter. Finally, TimesSquare Capital Management LLC bought a new position in Addus HomeCare in the 2nd quarter valued at $31,502,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.